A clinical decision support tool advocating penicillin allergy testing in patients taking aztreonam has the potential to improve antimicrobial stewardship and reduce costs, according to researchers.
“Penicillin allergy skin testing (PAST) is gaining recognition as a key component of antimicrobial stewardship,” they wrote in Open Forum Infectious Diseases. “The prevalence of reported penicillin allergy in hospitalized patients is approximately 10% to 20%; however, less than one in 10 individuals carrying this diagnosis is truly allergic.”
No commercial support for this activity.
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2018 Healio All Rights Reserved.